» Articles » PMID: 30262472

Neutrophil Extracellular Traps Produced During Inflammation Awaken Dormant Cancer Cells in Mice

Abstract

Cancer cells from a primary tumor can disseminate to other tissues, remaining dormant and clinically undetectable for many years. Little is known about the cues that cause these dormant cells to awaken, resume proliferating, and develop into metastases. Studying mouse models, we found that sustained lung inflammation caused by tobacco smoke exposure or nasal instillation of lipopolysaccharide converted disseminated, dormant cancer cells to aggressively growing metastases. Sustained inflammation induced the formation of neutrophil extracellular traps (NETs), and these were required for awakening dormant cancer. Mechanistic analysis revealed that two NET-associated proteases, neutrophil elastase and matrix metalloproteinase 9, sequentially cleaved laminin. The proteolytically remodeled laminin induced proliferation of dormant cancer cells by activating integrin α3β1 signaling. Antibodies against NET-remodeled laminin prevented awakening of dormant cells. Therapies aimed at preventing dormant cell awakening could potentially prolong the survival of cancer patients.

Citing Articles

Clinicopathological and molecular features of HR /HER2 breast cancer patients with distinct endocrine resistance patterns.

Zhang S, Wang H, Zhang H, Zhuang Q, Zhu X, Xiao Y Chin J Cancer Res. 2025; 37(1):48-65.

PMID: 40078562 PMC: 11893345. DOI: 10.21147/j.issn.1000-9604.2025.01.04.


Neutrophils take their PICk to promote breast cancer.

Tulotta C, Soehnlein O Nat Cancer. 2025; .

PMID: 40075236 DOI: 10.1038/s43018-025-00925-2.


Harnessing myeloid cells in cancer.

Park S, Pylaeva E, Bhuria V, Gambardella A, Schiavoni G, Mougiakakos D Mol Cancer. 2025; 24(1):69.

PMID: 40050933 PMC: 11887392. DOI: 10.1186/s12943-025-02249-2.


Prophylactic antibiotic use is associated with better clinical outcomes in gastric cancer patients receiving immunotherapy.

Zhang F, Ding Z, Lian Y, Yang X, Hu P, Liu Y Oncologist. 2025; 30(2).

PMID: 40036772 PMC: 11879193. DOI: 10.1093/oncolo/oyae362.


Liver Metastasis in Cancer: Molecular Mechanisms and Management.

Xu W, Xu J, Liu J, Wang N, Zhou L, Guo J MedComm (2020). 2025; 6(3):e70119.

PMID: 40027151 PMC: 11868442. DOI: 10.1002/mco2.70119.


References
1.
Watson R, Redmond H, Mc Carthy J, Bouchier-Hayes D . Taurolidine, an antilipopolysaccharide agent, has immunoregulatory properties that are mediated by the amino acid taurine. J Leukoc Biol. 1995; 58(3):299-306. DOI: 10.1002/jlb.58.3.299. View

2.
Pierce B, Ballard-Barbash R, Bernstein L, Baumgartner R, Neuhouser M, Wener M . Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol. 2009; 27(21):3437-44. PMC: 2717751. DOI: 10.1200/JCO.2008.18.9068. View

3.
El Rayes T, Catena R, Lee S, Stawowczyk M, Joshi N, Fischbach C . Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1. Proc Natl Acad Sci U S A. 2015; 112(52):16000-5. PMC: 4703007. DOI: 10.1073/pnas.1507294112. View

4.
Branzk N, Papayannopoulos V . Molecular mechanisms regulating NETosis in infection and disease. Semin Immunopathol. 2013; 35(4):513-30. PMC: 3685711. DOI: 10.1007/s00281-013-0384-6. View

5.
Catena R, Bhattacharya N, El Rayes T, Wang S, Choi H, Gao D . Bone marrow-derived Gr1+ cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1. Cancer Discov. 2013; 3(5):578-89. PMC: 3672408. DOI: 10.1158/2159-8290.CD-12-0476. View